PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. (Q46544691)
scientific article published on 12 June 2008
Language:
Current Data About PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML.
(P31) (Q13442814)
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P50) (Q51322110)
(P1545) 2
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(Q56167780)
(P1545) 3
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(Q48282150)
(P1545) 4
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(Q30347543)
(P1545) 7
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(Q56549745)
(P1545) 11
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(Q48282168)
(P1545) 15
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P304) 1698-1706
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P407) (Q1860)

(P433) 9
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P478) 22
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P577) Thursday, June 12, 2008
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P1433) (Q6534498)
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P1476) "PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML" (language: en)
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P2093) S Park
(P1545) 1
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

N Gallay
(P1545) 5
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

L Willems
(P1545) 6
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

K M Shokat
(P1545) 8
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

N Azar
(P1545) 9
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

F Viguié
(P1545) 10
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

F Dreyfus
(P1545) 12
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

P Mayeux
(P1545) 13
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

C Lacombe
(P1545) 14
(P248)
(P698) 18548104
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548104%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, January 8, 2020

(P2860) (Q36420012)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q34542144)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q44408364)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q53334759)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q44443469)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q57220263)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q27860757)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q35848196)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q45154681)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q53526869)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q40484084)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q24599676)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q37003323)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q40280414)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q43893064)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q28264038)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q36276756)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q36461618)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q40184405)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q46956224)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q40040911)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q40118489)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q40158710)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q59076083)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Sunday, January 21, 2018

(Q83350735)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Thursday, January 7, 2021
(P887)

(Q56995355)
(P248)
(P854) https://api.crossref.org/works/10.1038%2FLEU.2008.144
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on 12 June 2008

External Links
(P356) 10.1038/LEU.2008.144
(P698) 18548104
(P5875) 5309297